Literature DB >> 32386188

No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.

Mostafa Saadat1.   

Abstract

Entities:  

Keywords:  COVID-19; angiotensin-converting enzyme; polymorphism

Mesh：

Substances：

Year:  2020        PMID： 32386188     DOI： 10.1515/cclm-2020-0577

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  12 in total

1.  Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study.

Authors:  Serdal Baştuğ; Büşranur Çavdarlı; Aliye Baştuğ; İrfan Şencan; Ebru Tunçez; Esra Yakışık Çakır; Nizamettin Kemirtlek; Cihad Sakar; Deniz Erdem; Gülay Güleç Ceylan; Işıl Özkoçak Turan; Sümeyye Kazancıoğlu; Hürrem Bodur
Journal:  Anatol J Cardiol       Date:  2022-02       Impact factor: 1.596

Review 2.  Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.

Authors:  J A Hubacek
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

3.  Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.

Authors:  Mojtaba Najafi; Mohammad Reza Mahdavi
Journal:  Mol Genet Genomics       Date:  2022-10-18       Impact factor: 2.980

Review 4.  COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine.

Authors:  Naveen L Pereira; Ferhaan Ahmad; Mirnela Byku; Nathan W Cummins; Alanna A Morris; Anjali Owens; Sony Tuteja; Sharon Cresci
Journal:  Mayo Clin Proc       Date:  2020-12-03       Impact factor: 7.616

5.  Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?

Authors:  Nad Starčević Čizmarević; Marin Tota; Smiljana Ristić
Journal:  Croat Med J       Date:  2020-12-31       Impact factor: 1.351

6.  The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study.

Authors:  Arezoo Faridzadeh; Mahmoud Mahmoudi; Sara Ghaffarpour; Mohammad Saber Zamani; Akram Hoseinzadeh; Mohammad Mehdi Naghizadeh; Tooba Ghazanfari
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

7.  Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?

Authors:  Sanja Dević Pavlić; Sergej Nadalin; Nada Starčević Čizmarević; Alena Buretić-Tomljanović; Anđelka Radojčić Badovinac; Smiljana Ristić
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Jul-Sep       Impact factor: 1.636

8.  Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.

Authors:  Donato Gemmati; Veronica Tisato
Journal:  Genes (Basel)       Date:  2020-09-03       Impact factor: 4.096

9.  Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.

Authors:  Mona Alshahawey; Mohamed Raslan; Nagwa Sabri
Journal:  Curr Res Transl Med       Date:  2020-09-06       Impact factor: 4.513

Review 10.  Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.

Authors:  Emilio Di Maria; Andrea Latini; Paola Borgiani; Giuseppe Novelli
Journal:  Hum Genomics       Date:  2020-09-11       Impact factor: 4.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.